These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6132401)

  • 21. 1alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes and the development of gamma-glutamyltranspeptidase-positive foci in diethylnitrosamine-initiated and streptozotocin-induced diabetes-promoted hepatocarcinogenesis.
    Saha BK; Bhattacharya R; Chatterjee M
    Cell Biochem Funct; 2002 Sep; 20(3):195-204. PubMed ID: 12125095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-carotene inhibits persistent and stimulates remodeling gamma GT-positive preneoplastic lesions during early promotion of hepatocarcinogenesis.
    Rizzi MB; Dagli ML; Jordão AA; Penteado MV; Moreno FS
    Int J Vitam Nutr Res; 1997; 67(6):415-22. PubMed ID: 9433674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant expression of adaptation to phenobarbital may cause selective growth of foci of altered cells in rat liver.
    Schulte-Hermann R; Timmermann-Trosiener I; Schuppler J
    IARC Sci Publ; 1984; (56):67-75. PubMed ID: 6152623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diminished hepatic binding protein for desialylated glycoproteins during chemical hepatocarcinogenesis.
    Stockert RJ; Becker FF
    Cancer Res; 1980 Oct; 40(10):3632-4. PubMed ID: 7438047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The direct and indirect effects of promoters may depend upon the nature of the initiated cell.
    Becker FF
    Princess Takamatsu Symp; 1983; 14():349-59. PubMed ID: 6151564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased susceptibility of livers of aged F344/NCr rats to the effects of phenobarbital on the incidence, morphology, and histochemistry of hepatocellular foci and neoplasms.
    Ward JM
    J Natl Cancer Inst; 1983 Oct; 71(4):815-23. PubMed ID: 6194333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-examination of the ED01 study. Overview.
    Fundam Appl Toxicol; 1981; 1(1):28-63. PubMed ID: 7184773
    [No Abstract]   [Full Text] [Related]  

  • 28. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression.
    Chakraborty T; Chatterjee A; Rana A; Srivastawa S; Damodaran S; Chatterjee M
    Life Sci; 2007 Jul; 81(6):489-99. PubMed ID: 17651763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of varying the exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat.
    Peraino C; Fry RJ; Staffeldt E; Kisieleski WE
    Cancer Res; 1973 Nov; 33(11):2701-5. PubMed ID: 4748431
    [No Abstract]   [Full Text] [Related]  

  • 30. Re-examination of the ED01 study--technical discussion of the statistical analysis for adjusting for time on study.
    Fundam Appl Toxicol; 1981; 1(1):81-7. PubMed ID: 7184777
    [No Abstract]   [Full Text] [Related]  

  • 31. Sex steroid hormones levels and testicular activity during hepatocarcinogenesis by N-2-fluorenylacetamide.
    Lafaurie M; Aussel C; Castelli D; Krebs B; Stora C
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):49-63. PubMed ID: 6181546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic and morphologic studies of hepatocarcinogenesis in the rat. ANL-7409.
    Peraino C
    ANL Rep; 1967; ():165-6. PubMed ID: 5308222
    [No Abstract]   [Full Text] [Related]  

  • 33. Thyroid activity during hepatocarcinogenesis by N-2-fluorenylacetamide in the male rat.
    Aussel C; Lafaurie M; Castelli D; Formento JL; Stora C
    Res Commun Chem Pathol Pharmacol; 1982 Apr; 36(1):105-17. PubMed ID: 7079578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphological classification of mouse liver tumors based on biological characteristics.
    Becker FF
    Cancer Res; 1982 Oct; 42(10):3918-23. PubMed ID: 7104991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the tumor aldehyde dehydrogenase phenotype during 2-acetylaminofluorene-induced rat hepatocarcinogenesis.
    Lindahl R; Evces S; Sheng WL
    Cancer Res; 1982 Feb; 42(2):577-82. PubMed ID: 7055805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative systemic analysis of experimental models of chemical hepatic carcinogenesis in the rat].
    Lans M; de Gerlache J; Préat V; Taper H; Roberfroid M
    C R Seances Soc Biol Fil; 1984; 178(4):397-407. PubMed ID: 6151868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of dietary lipotrope and lipid content on aflatoxin B1, N-2-fluorenylacetamide, and 1,2-dimethylhydrazine carcinogenesis in rats.
    Rogers AE; Lenhart G; Morrison G
    Cancer Res; 1980 Aug; 40(8 Pt 1):2802-7. PubMed ID: 7388829
    [No Abstract]   [Full Text] [Related]  

  • 38. Absence of uniform progressive growth of long-term transplants of rat liver neoplastic nodules.
    Ohmori T; Watanabe K; Williams GM
    J Natl Cancer Inst; 1980 Aug; 65(2):485-90. PubMed ID: 6931264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro measurement of carcinogen-resistant liver cells during hepatocarcinogenesis.
    Laishes BA; Roberts E; Farber E
    Int J Cancer; 1978 Feb; 21(2):186-93. PubMed ID: 627426
    [No Abstract]   [Full Text] [Related]  

  • 40. Resistance to the cytocidal effects of adriamycin is an early phenotypic change induced during hepatocarcinogenesis.
    Carr BI; Laishes BA
    Br J Cancer; 1981 Oct; 44(4):567-71. PubMed ID: 7295513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.